{"id":391727,"date":"2020-12-02T08:43:37","date_gmt":"2020-12-02T13:43:37","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=391727"},"modified":"2020-12-02T08:43:37","modified_gmt":"2020-12-02T13:43:37","slug":"curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/","title":{"rendered":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data"},"content":{"rendered":"
\n

– KOL Event featuring Dr. Amit Verma scheduled for Tuesday, December 8 at 8:00 a.m. ET –<\/h2>\n

– Discussion of data from two Phase 1 studies of CA-4948 in patients with non-Hodgkin lymphoma and in patients with acute myeloid leukemia and myelodysplastic syndromes –<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n LEXINGTON, Mass.<\/span>, Dec. 2, 2020<\/span> \/PRNewswire\/ —\u00a0Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event on Tuesday, December 8, 2020<\/span>, at 8:00 am ET<\/span>. <\/p>\n

\n

\n
\n \"(PRNewsfoto\/Curis,
\n <\/a>\n <\/p>\n<\/p><\/div>\n

The event will discuss progress to date for first-in-class IRAK4 kinase inhibitor, CA-4948, including data presented at the 62nd American Society of Hematology Annual Meeting and Exposition from the Phase 1 study in patients with non-Hodgkin lymphoma and new clinical data from the Phase 1 study in patients with acute myeloid leukemia and myelodysplastic syndromes.<\/p>\n

The event will be led by James Dentzer<\/span>, President and CEO, and will include a presentation by Dr.\u00a0Amit\u00a0Verma,\u00a0Professor of Medicine-Oncology at Albert Einstein College of Medicine, and Director of the MDS Program at Montefiore Medical Center in Bronx<\/span>, NY. Dr Verma and members of Curis leadership will be available to answer questions at the end of the event.<\/p>\n

A live webcast of the presentation will be available under “Events & Presentations” in the Investors section of the Company’s website at www.curis.com<\/a>. A replay of the webcast will be available on the Curis website for 90 days following the event.<\/p>\n

\n About\u00a0Curis, Inc.<\/b>\n <\/p>\n

Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration\u00a0with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including, the VISTA\/PDL1 antagonist CA-170, and the TIM3\/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin lymphoma and in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1a\/1b<\/span> trial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedge\u00ae<\/sup> for the treatment of advanced basal cell carcinoma. For more information, visit Curis’ website at www.curis.com<\/a>. \u00a0<\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data-301183710.html<\/a><\/p>\n

SOURCE Curis, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

– KOL Event featuring Dr. Amit Verma scheduled for Tuesday, December 8 at 8:00 a.m. ET – – Discussion of data from two Phase 1 studies of CA-4948 in patients with non-Hodgkin lymphoma and in patients with acute myeloid leukemia and myelodysplastic syndromes – PR Newswire LEXINGTON, Mass., Dec. 2, 2020 \/PRNewswire\/ —\u00a0Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event on Tuesday, December 8, 2020, at 8:00 am ET. The event will discuss progress to date for first-in-class IRAK4 kinase inhibitor, CA-4948, including data presented at the 62nd American Society of Hematology Annual Meeting and Exposition from the Phase … <\/p>\n

Continue reading “Curis to Host Virtual Event to Discuss CA-4948 Clinical Data”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-391727","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCuris to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"– KOL Event featuring Dr. Amit Verma scheduled for Tuesday, December 8 at 8:00 a.m. ET – – Discussion of data from two Phase 1 studies of CA-4948 in patients with non-Hodgkin lymphoma and in patients with acute myeloid leukemia and myelodysplastic syndromes – PR Newswire LEXINGTON, Mass., Dec. 2, 2020 \/PRNewswire\/ —\u00a0Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event on Tuesday, December 8, 2020, at 8:00 am ET. The event will discuss progress to date for first-in-class IRAK4 kinase inhibitor, CA-4948, including data presented at the 62nd American Society of Hematology Annual Meeting and Exposition from the Phase … Continue reading "Curis to Host Virtual Event to Discuss CA-4948 Clinical Data"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-02T13:43:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data\",\"datePublished\":\"2020-12-02T13:43:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/\"},\"wordCount\":443,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/\",\"name\":\"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"datePublished\":\"2020-12-02T13:43:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/607886\\\/Curis_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/","og_locale":"en_US","og_type":"article","og_title":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk","og_description":"– KOL Event featuring Dr. Amit Verma scheduled for Tuesday, December 8 at 8:00 a.m. ET – – Discussion of data from two Phase 1 studies of CA-4948 in patients with non-Hodgkin lymphoma and in patients with acute myeloid leukemia and myelodysplastic syndromes – PR Newswire LEXINGTON, Mass., Dec. 2, 2020 \/PRNewswire\/ —\u00a0Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it will host a virtual KOL event on Tuesday, December 8, 2020, at 8:00 am ET. The event will discuss progress to date for first-in-class IRAK4 kinase inhibitor, CA-4948, including data presented at the 62nd American Society of Hematology Annual Meeting and Exposition from the Phase … Continue reading \"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-02T13:43:37+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data","datePublished":"2020-12-02T13:43:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/"},"wordCount":443,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/","name":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","datePublished":"2020-12-02T13:43:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/607886\/Curis_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/curis-to-host-virtual-event-to-discuss-ca-4948-clinical-data\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Curis to Host Virtual Event to Discuss CA-4948 Clinical Data"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=391727"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/391727\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=391727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=391727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=391727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}